Trial intelligence / Profile preview

ANRS darunavir/ritonavir monotherapy versus triple therapy maintenance in virologically suppressed HIV-1 adults

2006-005962-38Phase 3Completed

Sponsor
ANRS
Start
Dec 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of darunavir and ritonavir in Human immunodeficiency virus infection type 1 (2 arms), sponsored by ANRS. Started Dec 2006; status: completed.

02

Drugs

darunavirritonavir
03

Conditions

Human immunodeficiency virus infection type 1

Beyond the preview

Go deeper on 2006-005962-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005962-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call